Yang L - Search Results

1

USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity.

An S, Zhao LP, Shen LJ, Wang S, Zhang K, Qi Y, Zheng J, Zhang XJ, Zhu XY, Bao R, Yang L, Lu YX, She ZG, Tang YD. An S, et al. Among authors: yang l. Hepatology. 2017 Dec;66(6):1866-1884. doi: 10.1002/hep.29375. Epub 2017 Oct 30. Hepatology. 2017. PMID: 28718215

2

Exacerbating Pressure Overload-Induced Cardiac Hypertrophy: Novel Role of Adaptor Molecule Src Homology 2-B3.

Zhu X, Fang J, Jiang DS, Zhang P, Zhao GN, Zhu X, Yang L, Wei X, Li H. Zhu X, et al. Among authors: yang l. Hypertension. 2015 Sep;66(3):571-81. doi: 10.1161/HYPERTENSIONAHA.115.05183. Epub 2015 Jun 22. Hypertension. 2015. PMID: 26101343

3

Dusp14 protects against hepatic ischaemia-reperfusion injury via Tak1 suppression.

Wang X, Mao W, Fang C, Tian S, Zhu X, Yang L, Huang Z, Li H. Wang X, et al. Among authors: yang l. J Hepatol. 2017 Sep 6:S0168-8278(17)32275-4. doi: 10.1016/j.jhep.2017.08.032. Online ahead of print. J Hepatol. 2017. PMID: 28887166

4

Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1.

Qin JJ, Mao W, Wang X, Sun P, Cheng D, Tian S, Zhu XY, Yang L, Huang Z, Li H. Qin JJ, et al. Among authors: yang l. J Hepatol. 2018 Nov;69(5):1110-1122. doi: 10.1016/j.jhep.2018.06.014. Epub 2018 Jun 27. J Hepatol. 2018. PMID: 29958938

5

Creg in Hepatocytes Ameliorates Liver Ischemia/Reperfusion Injury in a TAK1-Dependent Manner in Mice.

Yang L, Wang W, Wang X, Zhao J, Xiao L, Gui W, Fan H, Xia J, Li Z, Yan J, Alasbahi A, Zhu Q, Hou X. Yang L, et al. Hepatology. 2019 Jan;69(1):294-313. doi: 10.1002/hep.30203. Hepatology. 2019. PMID: 30076625

6

Corrigendum to "Caspase recruitment domain 6 protects against hepatic ischemia/reperfusion injury by suppressing ASK1" [J Hepatol 69 (2018) 1110-1122].

Qin JJ, Mao W, Wang X, Sun P, Cheng D, Tian S, Zhu XY, Yang L, Huang Z, Li H. Qin JJ, et al. Among authors: yang l. J Hepatol. 2019 Mar;70(3):578-580. doi: 10.1016/j.jhep.2018.11.001. Epub 2019 Jan 4. J Hepatol. 2019. PMID: 30616986 No abstract available.

7

Tumor Necrosis Factor α-Induced Protein 8-Like 2 Alleviates Nonalcoholic Fatty Liver Disease Through Suppressing Transforming Growth Factor Beta-Activated Kinase 1 Activation.

Liu Y, Song J, Yang J, Zheng J, Yang L, Gao J, Tian S, Liu Z, Meng X, Wang JC, Dai Z, Tang YD. Liu Y, et al. Among authors: yang l, yang j. Hepatology. 2021 Sep;74(3):1300-1318. doi: 10.1002/hep.31832. Epub 2021 Jul 26. Hepatology. 2021. PMID: 33768585

8

Gastrodin Improves Nonalcoholic Fatty Liver Disease Through Activation of the Adenosine Monophosphate-Activated Protein Kinase Signaling Pathway.

Wan J, Zhang Y, Yang D, Liang Y, Yang L, Hu S, Liu Z, Fang Q, Tian S, Ding Y. Wan J, et al. Among authors: yang d, yang l. Hepatology. 2021 Dec;74(6):3074-3090. doi: 10.1002/hep.32068. Epub 2021 Sep 24. Hepatology. 2021. PMID: 34297426

9

SIMPLE Is an Endosomal Regulator That Protects Against NAFLD by Targeting the Lysosomal Degradation of EGFR.

Song J, Liu Y, Wan J, Zhao GN, Wang JC, Dai Z, Hu S, Yang L, Liu Z, Fu Y, Dong E, Tang YD. Song J, et al. Among authors: yang l. Hepatology. 2021 Dec;74(6):3091-3109. doi: 10.1002/hep.32075. Epub 2021 Nov 2. Hepatology. 2021. PMID: 34320238

10

Melanoma differentiation-Associated gene 5 protects against NASH in mice.

Zhang X, Yang H, Zeng S, Tian S, Hu S, Yang L, Ma T, Liu Z, Wan J, Zhong Y, Li H. Zhang X, et al. Among authors: yang l, yang h. Hepatology. 2022 Apr;75(4):924-938. doi: 10.1002/hep.32139. Epub 2021 Dec 13. Hepatology. 2022. PMID: 34482560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56,693 results

Search Page

Filters